CoChat

The clinical management of bipolar disorder complexity using a stratified model

Malhi, Gin S, Bargh, Danielle M, Cashman, Emma, Frye, Mark A, Gitlin, Michael · 2012 · Bipolar Disorders
Cited by 49

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Malhi GS, Bargh DM, Cashman E, Frye MA, Gitlin M. The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disord 2012: 14 (Suppl. 2): 66–89. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S. Objective: To provide practical and clinically meaningful treatment recommendations that amalgamate clinical and research considerations for several common, and as yet understudied, bipolar disorder complex presentations, within the framework of a proposed stratified model. Methods: A comprehensive search of the literature was undertaken using electronic database search engines (Medline, PubMed, Web of Science) using key words (e.g., bipolar disorder, anxiety, rapid cycling, and subsyndromal). All relevant randomised controlled trials were examined, in addition to review papers, meta‐analyses, and book chapters known to the authors. The findings formed the basis of the treatment recommendations within this paper. Results: In light of the many broad presentations of bipolar disorder, a stratified model of bipolar disorder complexity was developed to facilitate consideration of the myriad of complexities that can occur during the longitudinal course of illness and the appropriate selection of treatment. Evidence‐based treatment recommendations are provided for the following bipolar disorder presentations: bipolar II disorder, subsyndromal symptoms, mixed states, rapid cycling, comorbid anxiety, comorbid substance abuse, and for the following special populations: young, elderly, and bipolar disorder around the time of pregnancy and birth. In addition, some key strategies for countering treatment non‐response and alternative medication recommendations are provided. Conclusions: Treatment recommendations for the more challenging presentations of bipolar disorder have historically received less attention, despite their prevalence. This review acknowledges the weaknesses in the current evidence base on which treatment recommendations are generally formulated, and additionally emphasises the need for high‐quality research in this area. The stratified model provides a means for conceptualizing the complexity of many bipolar disorder presentations and considering their management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2012.00993.x

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 198

  1. 10.1016/j.jad.2009.05.022 · DOI · Paper page
  2. 10.4088/JCP.v63n1105 · DOI · Paper page
  3. National Health, 1998, A guide to the development, implementation and evaluation of clinical practice guidelines
  4. 10.2165/11318850-000000000-00000 · DOI
  5. Malhi GS, 2010, The pharmacological treatment of bipolar disorder in primary care, Med J Aust, 193, 24
  6. 10.4088/JCP.v66n0609 · DOI · Paper page
  7. 10.1176/appi.ajp.161.12.2222 · DOI · Paper page
  8. 10.1111/j.1600-0447.2009.01383.x · DOI · Paper page
  9. 2005, Diagnostic and Statistical Manual of Mental Disorders
  10. 10.1111/j.1600-0447.2010.01638.x · DOI · Paper page
  11. 10.1016/S0165-0327(02)00332-4 · DOI · Paper page
  12. 10.4088/JCP.09r05192gre · DOI · Paper page
  13. 10.4088/JCP.v69n1009 · DOI · Paper page
  14. 10.1017/S0033291705006823 · DOI · Paper page
  15. Joyce PR, 2004, Bipolar II disorder: personality and outcome in two clinical samples, Aust N Z J Psychiatry, 38, 433, 10.1080/j.1440-1614.2004.01380.x · DOI
  16. 10.1037/a0023973 · DOI · Paper page
  17. 10.1001/archgenpsychiatry.2009.158 · DOI · Paper page
  18. 10.1016/j.jad.2008.02.004 · DOI · Paper page
  19. 10.1016/j.jad.2009.10.021 · DOI
  20. 10.1016/S0165-0327(01)00434-7 · DOI
  21. 10.1111/j.1399-5618.2007.00500.x · DOI · Paper page
  22. 10.1016/j.jad.2008.03.029 · DOI
  23. 10.1097/JCP.0b013e3181da5300 · DOI · Paper page
  24. 10.1016/j.jad.2008.01.029 · DOI
  25. 10.1016/j.pnpbp.2010.07.020 · DOI
  26. 10.1001/archpsyc.1976.01770010073014 · DOI · Paper page
  27. 10.1176/ajp.133.8.925 · DOI · Paper page
  28. 10.1016/S0140-6736(09)61828-6 · DOI · Paper page
  29. 10.1016/j.jad.2008.03.023 · DOI
  30. 10.1111/j.1399-5618.2008.00629.x · DOI · Paper page
  31. 10.1016/S0165-0327(00)00203-2 · DOI · Paper page
  32. 10.1111/j.1399-5618.2010.00872.x · DOI
  33. 10.1007/s00406-011-0228-0 · DOI
  34. 10.1001/archgenpsychiatry.2011.87 · DOI · Paper page
  35. 10.1007/s00406-003-0433-6 · DOI
  36. 10.1016/j.jad.2008.07.006 · DOI · Paper page
  37. 10.1034/j.1399-5618.2003.00048.x · DOI · Paper page
  38. Bernhard B, 2006, Levetiracetam add‐on treatment for bipolar patients suffering from subsyndromal symptoms: preliminary data of an open 6‐months longitudinal study, Bipolar Disord, 8
  39. 10.1111/j.1755-5949.2011.00236.x · DOI · Paper page
  40. 10.1016/j.jad.2009.10.027 · DOI
  41. 10.1016/j.jad.2006.10.027 · DOI
  42. 10.1176/appi.ajp.160.12.2099 · DOI · Paper page
  43. 10.1016/j.jad.2007.05.027 · DOI
  44. 10.1017/S1461145705005948 · DOI
  45. 10.1016/S0165-0327(01)00443-8 · DOI · Paper page
  46. 10.1186/1471-244X-9-33 · DOI · Paper page
  47. 10.1111/j.1399-5618.2007.00553.x · DOI · Paper page
  48. 10.1016/j.jad.2008.11.003 · DOI
  49. Houston JP, 2011, Olanzapine‐divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double‐blind, placebo‐controlled study, J Clin Psychiatry, 72, 1157
  50. 10.1016/j.pnpbp.2007.01.006 · DOI
  51. 10.1177/0269881108099418 · DOI · Paper page
  52. 10.1176/appi.ajp.160.4.741 · DOI · Paper page
  53. 10.1097/01.jcp.0000169068.34322.70 · DOI · Paper page
  54. 10.1111/j.1399-5618.2009.00748.x · DOI · Paper page
  55. 10.1016/j.jad.2007.08.015 · DOI
  56. 10.4088/JCP.v67n1003 · DOI · Paper page
  57. Schneck CD, 2006, Treatment of rapid‐cycling bipolar disorder, J Clin Psychiatry, 67, 22
  58. 10.1002/pmh.78 · DOI · Paper page
  59. 10.1016/j.comppsych.2010.02.006 · DOI
  60. 10.1001/archpsyc.60.9.914 · DOI · Paper page
  61. 10.1176/appi.ajp.2007.05081484 · DOI · Paper page
  62. 10.1016/j.jad.2008.12.005 · DOI
  63. 10.4088/JCP.09m05514yel · DOI · Paper page
  64. 10.1111/j.1399-5618.2009.00713.x · DOI
  65. 10.1016/S0165-0327(02)00334-8 · DOI
  66. 10.1097/00004714-199202001-00008 · DOI · Paper page
  67. 10.4088/JCP.v58n1102 · DOI · Paper page
  68. 10.1001/archpsyc.1990.01810170035006 · DOI · Paper page
  69. 10.1192/bjp.bp.110.085316 · DOI · Paper page
  70. 10.1192/bjp.bp.111.100586 · DOI
  71. 10.4088/JCP.08m04633 · DOI
  72. 10.1016/j.jpsychires.2009.09.011 · DOI · Paper page
  73. 10.1521/pedi.2010.24.6.763 · DOI · Paper page
  74. 10.1097/NMD.0b013e31818b481d · DOI · Paper page
  75. 10.1016/j.jad.2009.06.007 · DOI
  76. 10.1080/13651500500305481 · DOI
  77. 10.1053/comp.2003.50009 · DOI
  78. 10.1111/j.1601-5215.2004.00074.x · DOI
  79. 10.1038/sj.npp.1300608 · DOI
  80. 10.1097/01.psy.0000237316.09601.88 · DOI · Paper page
  81. 10.1002/da.20053 · DOI · Paper page
  82. 10.1159/000241193 · DOI
  83. 10.1111/j.1399-5618.2008.00461.x · DOI · Paper page
  84. 10.4088/JCP.09m05019yel · DOI
  85. 10.4088/JCP.v67n0902 · DOI · Paper page
  86. 10.1001/archgenpsychiatry.2007.18 · DOI · Paper page
  87. 10.1176/appi.ajp.163.2.232 · DOI · Paper page
  88. 10.1016/S0165-0327(00)00299-8 · DOI · Paper page
  89. 10.1016/j.jad.2010.10.040 · DOI
  90. 10.4088/JCP.v68n1203 · DOI · Paper page
  91. 10.1111/j.1600-0447.2007.01059.x · DOI
  92. 10.1176/appi.ajp.2009.09020299 · DOI · Paper page
  93. 10.1111/j.1742-1241.2009.02284.x · DOI
  94. 10.1016/j.comppsych.2008.06.008 · DOI · Paper page
  95. 10.1016/S0006-3223(00)00900-8 · DOI · Paper page
  96. 10.1016/j.jad.2008.08.019 · DOI
  97. 10.1016/j.jpsychires.2008.05.001 · DOI
  98. 10.1016/j.psychres.2007.09.009 · DOI · Paper page
  99. Azorin J‐M, 2010, Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism, Neuropsychiatr Dis Treat, 6, 37
  100. 10.1097/NMD.0b013e3181ef3ef4 · DOI
  101. 10.3928/00485713-20081101-09 · DOI
  102. 10.1016/j.biopsych.2004.07.019 · DOI
  103. Brady KT, 1995, Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study, J Clin Psychiatry, 56, 118
  104. 10.1080/02791072.2001.10400575 · DOI
  105. 10.1111/j.1399-5618.2006.00292.x · DOI · Paper page
  106. 10.4088/JCP.v64n0213 · DOI · Paper page
  107. 10.4088/JCP.v69n0502 · DOI · Paper page
  108. 10.1002/hup.944 · DOI · Paper page
  109. 10.1016/j.psychres.2011.04.030 · DOI
  110. 10.1111/j.1399-5618.2005.00234.x · DOI · Paper page
  111. 10.1111/j.1399-5618.2007.00520.x · DOI · Paper page
  112. 10.1016/j.genhosppsych.2010.09.005 · DOI
  113. 10.1111/j.1399-5618.2012.00989.x · DOI · Paper page
  114. 10.1111/j.1399-5618.2009.00737.x · DOI · Paper page
  115. 10.1001/archpsyc.64.9.1032 · DOI · Paper page
  116. 10.1016/j.jad.2009.02.010 · DOI
  117. 10.1007/s11920-005-0006-7 · DOI
  118. 10.1097/01.chi.0000242240.69678.c4 · DOI · Paper page
  119. 10.1016/j.pcl.2010.10.001 · DOI
  120. 10.2165/11539700-000000000-00000 · DOI
  121. 10.1176/appi.ajp.2007.06111932 · DOI · Paper page
  122. 10.1097/01.chi.0000194567.63289.97 · DOI · Paper page
  123. DelBello MP, 2008, Efficacy and safety of ziprasidone in pediatric bipolar disorder
  124. 10.1016/S0924-977X(09)71103-4 · doi:10.1016/s0924-977x(09)71103-4
  125. 10.1111/j.1399-5618.2009.00750.x · DOI · Paper page
  126. 10.4088/JCP.09m05164yel · DOI · Paper page
  127. 10.1097/00004583-200210000-00011 · DOI · Paper page
  128. 10.1111/j.1399-5618.2009.00728.x · DOI · Paper page
  129. 10.1089/cap.2010.0102 · DOI
  130. 10.1089/cap.2006.16.336 · DOI
  131. 10.1016/j.psc.2011.02.007 · DOI
  132. 10.1001/archpsyc.62.6.593 · DOI · Paper page
  133. 10.1002/gps.1527 · DOI
  134. 10.2165/11537700-000000000-00000 · DOI
  135. 10.1097/00019442-200504000-00008 · DOI
  136. Hirschfeld RMA, 2002, Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, 159, 1
  137. 10.4088/JCP.v60n0306 · DOI · Paper page
  138. 10.1176/ajp.137.8.941 · DOI
  139. 10.1001/archpsyc.62.8.860 · DOI · Paper page
  140. 10.1192/bjp.bp.106.029868 · DOI · Paper page
  141. 10.3109/00048674.2011.610296 · DOI · Paper page
  142. 10.1097/00019442-199808000-00008 · DOI
  143. 10.1016/j.psc.2005.09.011 · DOI
  144. 10.4088/JCP.v69n0106 · DOI · Paper page
  145. 10.3109/10401239909147059 · doi:10.3109/10401239909147059
  146. Shulman RW, 1997, Treatment of elderly institutionalized bipolar patients with clozapine, Psychopharmacol Bull, 33, 113
  147. 10.4088/JCP.v67n0408 · DOI · Paper page
  148. 10.1176/appi.ajp.158.6.906 · DOI · Paper page
  149. 10.1002/gps.2016 · DOI
  150. 10.1111/j.1399-5618.2007.00397.x · DOI
  151. 10.1016/S0165-0327(99)00197-4 · DOI
  152. 10.4088/JCP.v63n0403 · DOI · Paper page
  153. 10.1016/j.jad.2009.05.019 · DOI
  154. 10.3109/00048670903487217 · DOI · Paper page
  155. National Collaborating Centre for Mental Health, 2006, The management of bipolar disorder in adults, children and adolescents, in primary and secondary care, 1
  156. 10.1111/j.1479-828X.2007.00781.x · DOI · Paper page
  157. 10.2165/00023210-200822040-00004 · DOI
  158. 10.1111/j.1528-1157.2000.tb00253.x · DOI
  159. 10.1016/0140-6736(92)90346-5 · DOI · Paper page
  160. Troyer WA, 1993, Association of maternal lithium exposure and premature delivery, J Perinatol, 13, 123
  161. 10.1001/jama.1994.03510260078033 · DOI · Paper page
  162. 10.1192/bjp.bp.107.041541 · DOI · Paper page
  163. 10.1097/00004714-200008000-00002 · DOI · Paper page
  164. 10.1111/j.1399-5618.2006.00295.x · DOI · Paper page
  165. 10.1176/ps.49.8.1081 · DOI · Paper page
  166. 10.1016/0924-9338(96)88396-9 · DOI
  167. Ernst CL, 2002, The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad‐spectrum psychotropics, J Clin Psychiatry, 63, 42
  168. 10.1056/NEJMoa067407 · DOI · Paper page
  169. 10.1111/j.0013-9580.2004.451105.x · DOI
  170. 10.1111/j.1399-5618.2009.00672.x · DOI · Paper page
  171. 10.1097/PSY.0b013e318190d7ca · DOI · Paper page
  172. 10.1176/appi.ajp.2011.11010148 · DOI · Paper page
  173. 10.1016/j.jad.2009.09.014 · DOI
  174. 10.1038/sj.mp.4001793 · DOI · Paper page
  175. 10.1111/j.1600-0447.2009.01471.x · DOI · Paper page
  176. Buckley PF, 2008, Strategies for dosing and switching antipsychotics for optimal clinical management, J Clin Psychiatry, 69, 4
  177. Ketter TA, 2008, Monotherapy versus combined treatment with second‐generation antipsychotics in bipolar disorder, J Clin Psychiatry, 69, 9
  178. 10.1016/S0193-953X(05)70285-9 · DOI
  179. 10.1080/15622970701805491 · DOI
  180. 10.1111/j.1600-0447.2009.01381.x · DOI
  181. 10.4088/JCP.08m04152 · DOI · Paper page
  182. Lauder SD, 2010, The role of psychotherapy in bipolar disorder, Med J Aust, 193, 31
  183. 10.1016/S0006-3223(00)00980-X · DOI
  184. 10.1097/YCT.0b013e3181b00f1e · DOI · Paper page
  185. 10.1097/YCT.0b013e3181ce1a8c · DOI · Paper page
  186. 10.1016/j.biopsych.2008.04.036 · DOI
  187. Papatheodorou G, 1995, The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent‐onset bipolar disorder, J Psychiatry Neurosci, 20, 226
  188. 10.1016/j.jad.2006.05.036 · DOI
  189. 10.1176/ajp.154.10.1456 · DOI · Paper page
  190. 10.4088/JCP.v58n0301 · DOI · Paper page
  191. 10.4088/JCP.v66n0204 · DOI · Paper page
  192. 10.1192/bjp.184.4.337 · DOI · Paper page
  193. 10.1176/appi.ajp.163.2.210 · DOI · Paper page
  194. 10.1176/appi.ajp.161.3.564 · DOI · Paper page
  195. 10.1097/YIC.0b013e3282f2b4c5 · DOI
  196. 10.4088/JCP.v67n0318 · doi:10.4088/jcp.v67n0318
  197. 10.1097/00004714-200208000-00017 · DOI
  198. 10.1097/00004714-200106000-00015 · DOI

Cited by

See all 49

Metadata

Authors
Malhi, G. S., Bargh, D. M., Cashman, E., Frye, M. A., & Gitlin, M.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2012-04-17
Volume
14
Issue
s2
Pages
66-89
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W1946171215
Cited by
49
References
63
FWCI
6.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.